期刊文献+

整合素阻断多肽HM-3体外抑制新生血管的研究 被引量:3

HM-3 Inhibiting Angiogenesis in Vitro
原文传递
导出
摘要 研究整合素阻断多肽HM-3体外对血管生成的作用。应用鸡胚尿囊膜实验、大鼠动脉环实验及Matrigel实验考察整合素阻断多肽HM-3抗血管生成作用。结果:鸡胚尿囊膜实验和大鼠动脉环实验表明HM-3能够抑制体外血管生成,多肽HM-3 0.05μg对鸡胚尿囊膜新生血管生成的抑制作用最强,多肽HM-3 8μg/mL对大鼠动脉环微血管生成抑制作用最强。Matrigel实验表明HM-3 7~8μg/mL对内皮细胞生长因子添加剂(ECGS)诱导的HUVEC细胞体外分化成管状结构抑制作用最强。整合素阻断多肽HM-3具有显著的体外抗血管生成的作用。 To investigate the inhibitory effect of HM-3 on angiogenesis in vitro.HM-3 antiangiogenesis effect was evaluated by using chick chorioallantonic membrane,rats aortic rings and Matrigel assay.Chick chorioallantoic membrane and rats aortic rings tests demonstrated that HM-3 effectively inhibited angiogenesis in vitro,the peptide HM-3 at the dose of 0.05 μg revealed the best inhibitory effect on chick chorioallantoic membrane.The most obvious effect on angiogenesis inhibition was observed at dose of 8 μg/mL on rats aortic rings.The most obvious blocking effect on the differentiation of HUVECs into tube-like structures was observed in vitro when the concentration of HM-3 was 7-8 μg/mL.Therefore HM-3 distinguishedly inhibited angiagenesis formed in vitro.
出处 《药物生物技术》 CAS CSCD 2012年第2期129-133,共5页 Pharmaceutical Biotechnology
基金 江苏省科技厅产学研联合创新资金-前瞻性联合研究项目(SBY2010-20063)
关键词 整合素阻断多肽HM-3 血管生成抑制 鸡胚尿囊膜实验 大鼠动脉环实验 Matrigel实验 HM-3 Antiangiogenesis Chick chorioallantonic membrane Rats aortic rings Tube formation
  • 相关文献

参考文献10

  • 1徐寒梅,陈罗胜,殷润婷,奚涛.人内皮抑素部分序列——Es-2的生物活性研究[J].中国药科大学学报,2006,37(4):346-348. 被引量:5
  • 2Albert F S,,Alla B Z,Rhian C M.Angiogenesis:An Improved InVitro Biological System and Automated Image-Based Workflow toAid Identification and Characterization of Angiogenesis andAngiogenic Modulators[].Assay and Drug Development Technol-ogies.2008
  • 3Xu H M,Pan L,Ren Y L,et al.RGD-modified angiogenesisinhibitor HM-3 dose:dual function during cancer treatment[].Bioconjugate Chemistry.2011
  • 4Folkman J.Tumour angiogenesis[].Cancer medicine.2000
  • 5Maragoudakis M E,Panoutsacopoulou M,Sarmonika M.Rate ofbasement membrane biosynthesis as an index to angiogenesis[].Tissue and Cell.1988
  • 6Folkman J.Tumor angiogenesis: therapeutic implications[].New England Journal of Medicine The.1971
  • 7Nyberg P,Xie L,Kalluri R,et al.Endogenous Inhibitors of Angiogenesis[].Cancer Research.2005
  • 8Kerbel R,Folkman J.Clinical translation of angiogenesis inhibitors[].Nature Reviews Cancer.2002
  • 9Virchow,R. Die krankhaften Geschwülste . 1863
  • 10Hannalnan D,et al.The hallmarks of cancer[]..2000

二级参考文献7

  • 1章良,韦利军,黄凤杰,吴梧桐.蛋白保护剂对蛇毒抗肿瘤活性物质ACTX-6的保护作用[J].中国药科大学学报,2005,36(2):183-186. 被引量:1
  • 2O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an andogenous inhibitor of angiogenesis and tumor growth [ J ]. Cell, 1997,88 (2) :277 - 285.
  • 3Xu HM, Zhang GY, Ji XD, et al. Expression of soluble, biologically active recombinant human endostatin in E. coli [ J ]. Protein Expr Purif, 2005,41(2) :252 - 258.
  • 4Dhanabal M, Volk R, Ramchandran R, et al. Cloning, expression,and in vitro activity of human endostatin[J]. Biochem Biophys ResCommun, 1999,258(2) :345 - 352.
  • 5Cattaneo MG, Pola S, Fmncescato P, et al. Human endostatin-defived synthetic possess potent antiangiogenic properties in vitro and in vivo[J]. Exp Cell Res ,2003,283(2) :230 - 236.
  • 6Sara A, Wickstrom, Kari Alitalo, et al. An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells[J]. J Biol Chem,2004,279(9):20 178-20 185.
  • 7Jia LJ, Xu HM, Ma DY, et al. Enhanced therapeutic effect by combination of tumor-targeting salmonella and endostatin in murine melanoma model[J]. Cancer Biol Ther,2005,4(8) :840 - 845.

共引文献4

同被引文献28

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部